Skip to content
mapperlab
← Dashboard
Stock

KRMD

KORU MEDICAL SYSTEMS, INC.
Latest close $3.833 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
3
27 funds tracked
Ever held
4
Current + past
New this quarter
1
Exited this quarter
1

Marquee-fund ownership over time

Aug 14, 2024Nov 13, 2025Feb 17, 2026May 15, 2026
Now
3

This quarter's activity

New positions opened

Positions exited

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Citadel Advisors re-entered$2.31$3.83+66%
Renaissance Technologies re-entered$3.20$3.83+20%
Two Sigma Investments$4.67$3.83-18%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Millennium Management→ $3.90+69%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at KORU Medical Systems, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
8
Filings · last 90d
19
Total on file
468
Recent SEC buffer
Most recent
May 20, 2026

30d / 90d windows measured from May 20, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 468 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · KORU MEDICAL SYSTEMS, INC.

Annual figures sourced directly from KORU MEDICAL SYSTEMS, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$41.13M
FY2025+22% YoY
Net income
-$2.64M
FY2025+57% YoY
EPS (diluted)
$-0.0600
FY2025+54% YoY
Free cash flow(?)
$462.41K
FY2025+245% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for KORU Medical Systems, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Renaissance TechnologiesQ2 2026open$3.98$3.83-4%
Citadel AdvisorsQ1 2026open$4.67$3.83-18%
Two Sigma InvestmentsQ1 2026open$4.67$3.83-18%
Renaissance TechnologiesQ4 2024Q4 2025$3.20$4.35+36%
Citadel AdvisorsQ3 2024Q4 2025$2.31$4.32+87%
Millennium ManagementQ3 2024Q2 2026$2.31$3.90+69%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.